Renaissance Technologies »

Oncolytics Biotech shares owned by Renaissance Technologies

Quarter-by-quarter ownership of Oncolytics Biotech (ONCY) shares owned by Renaissance Technologies from 13F filings

Historical chart of Renaissance Technologies investment in Oncolytics Biotech

Tip: Access up to 7 years of quarterly data

All positions including Oncolytics Biotech held by Renaissance Technologies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oncolytics Biotech by Renaissance Technologies

Quarter filed Position value Share count Share price at filing
2026-06-30 $59k 62k 0.95

More positions owned by Renaissance Technologies

NVIDIA Corporation (NVDA)
Meta Platforms Cl A (META)
Intel Corporation (INTC)
United Therapeutics Corporation (UTHR)
Palantir Technologies Cl A (PLTR)
Alphabet Cap Stk Cl A (GOOGL)
Exelixis (EXEL)
Verisign (VRSN)
Kinross Gold Corp (KGC)
Crowdstrike Hldgs Cl A (CRWD)
Sterling Construction Company (STRL)
Alphabet Cap Stk Cl C (GOOG)
Amazon (AMZN)
Argan (AGX)
Netflix (NFLX)

View all positions for Renaissance Technologies

Top funds holding Oncolytics Biotech

Marshall Wace
XTX Topco
Seeds Investor
International Assets Investment Management
Connective Capital Management
Goldman Sachs Group
Tocqueville Asset Management
Everhart Financial Group
Susquehanna International
PFG Investments
Hrt Financial
Invesco
Doliver Capital Advisors
LPL Financial
Franklin Resources

View all funds holding Oncolytics Biotech